Using distinct molecular signatures of human monocytes and dendritic cells to predict adjuvant activity and pyrogenicity of TLR agonists

Kamgang, Richard Kenmoe; Ramos, Inês; Rodrigues Duarte, Lurdes; Ghielmetti, Mascia; Freudenberg, Marina; Dahinden, Clemens; Padovan, Elisabetta (2008). Using distinct molecular signatures of human monocytes and dendritic cells to predict adjuvant activity and pyrogenicity of TLR agonists. Medical microbiology and immunology, 197(4), pp. 369-79. Berlin: Springer 10.1007/s00430-008-0081-6

[img]
Preview
Text
s00430-008-0081-6.pdf - Published Version
Available under License Publisher holds Copyright.

Download (734kB) | Preview

We present a systematic study that defines molecular profiles of adjuvanticity and pyrogenicity induced by agonists of human Toll-like receptor molecules in vitro. Using P(3)CSK(4), Lipid A and Poly I:C as model adjuvants we show that all three molecules enhance the expansion of IFNgamma(+)/CD4(+) T cells from their naïve precursors following priming with allogeneic DC in vitro. In contrast, co-culture of naive CD4(+) T cells with allogeneic monocytes and TLR2/TLR4 agonists only resulted in enhanced T cell proliferation. Distinct APC molecular signatures in response to each TLR agonist underline the dual effect observed on T cell responses. Using protein and gene expression assays, we show that TNF-alpha and CXCL10 represent DC-restricted molecular signatures of TLR2/TLR4 and TLR3 activation, respectively, in sharp contrast to IL-6 produced by monocytes upon stimulation with P(3)CSK(4) and Lipid A. Furthermore, although all TLR agonists are able to up-regulate proIL-1beta specific gene in both cell types, only monocyte activation with Lipid A results in detectable IL-1beta release. These molecular profiles, provide a simple screen to select new immune enhancers of human Th1 responses suitable for clinical application.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Rheumatologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Rheumatologie

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute for Immunology [discontinued]

UniBE Contributor:

Kamgang Kenmoe, Richard, Dahinden, Clemens A.

ISSN:

0300-8584

ISBN:

18283493

Publisher:

Springer

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:04

Last Modified:

05 Dec 2022 14:19

Publisher DOI:

10.1007/s00430-008-0081-6

PubMed ID:

18283493

Web of Science ID:

000258760500005

BORIS DOI:

10.48350/27947

URI:

https://boris.unibe.ch/id/eprint/27947 (FactScience: 114321)

Actions (login required)

Edit item Edit item
Provide Feedback